Literature DB >> 15073147

VEGFA is necessary for chondrocyte survival during bone development.

Elazar Zelzer1, Roni Mamluk, Napoleone Ferrara, Randall S Johnson, Ernestina Schipani, Bjorn R Olsen.   

Abstract

To directly examine the role of vascular endothelial growth factor (VEGFA) in cartilage development, we conditionally knocked out Vegfa in chondrocytes, using the Col2a1 promoter to drive expression of Cre recombinase. Our study of Vegfa conditional knockout (CKO) mice provides new in-vivo evidence for two important functions of VEGFA in bone formation. First, VEGFA plays a significant role in both early and late stages of cartilage vascularization, since Vegfa CKO mice showed delayed invasion of blood vessels into primary ossification centers and delayed removal of terminal hypertrophic chondrocytes. Second, VEGFA is crucial for chondrocyte survival, since massive cell death was seen in joint and epiphyseal regions of Vegfa CKO endochondral bones. Chondrocytes in these regions were found to upregulate expression of Vegfa in wild-type mice at the time when massive cell death occurred in the Vegfa CKO mice. The expression of the VEGFA receptors Npr1 and Npr2 in epiphyseal chondrocytes and lack of blood vessel reduction in the vicinity of the cartilaginous elements in the Vegfa CKO mice raise the possibility that the observed cell death is the result of a direct involvement of VEGFA in chondrocyte survival. Interestingly, the extensive cell death seen in Vegfa CKO null bones had a striking similarity to the cell death phenotype observed when hypoxia-inducible factor 1 alpha (Hif1a) expression was abolished in developing cartilage. This similarity of cell death phenotypes and the deficient VEGFA production in Hif1a null epiphyseal chondrocytes demonstrate that HIF1 alpha and VEGFA are components of a key pathway to support chondrocyte survival during embryonic bone development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073147     DOI: 10.1242/dev.01053

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  154 in total

1.  Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.

Authors:  Gary E Gallick; Paul G Corn; Amado J Zurita; Sue-Hwa Lin
Journal:  Future Med Chem       Date:  2012-01       Impact factor: 3.808

Review 2.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

Review 3.  Current insights on the regenerative potential of the periosteum: molecular, cellular, and endogenous engineering approaches.

Authors:  Céline Colnot; Xinping Zhang; Melissa L Knothe Tate
Journal:  J Orthop Res       Date:  2012-07-09       Impact factor: 3.494

4.  Role of the protease corin in chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells.

Authors:  Haibin Zhou; Jinsong Zhu; Meng Liu; Qingyu Wu; Ningzheng Dong
Journal:  J Tissue Eng Regen Med       Date:  2017-11-15       Impact factor: 3.963

5.  Mapping of the chromosome 17 BMD QTL in the F(2) male mice of MRL/MpJ x SJL/J.

Authors:  Hongrun Yu; Bouchra Edderkaoui; Alejandro Cortez; Heather M Davidson; Jon E Wergedal; David J Baylink; Subburaman Mohan
Journal:  Genetica       Date:  2008-03-11       Impact factor: 1.082

Review 6.  Contribution of endothelial cells to organogenesis: a modern reappraisal of an old Aristotelian concept.

Authors:  E Crivellato; B Nico; D Ribatti
Journal:  J Anat       Date:  2007-08-07       Impact factor: 2.610

7.  The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation.

Authors:  Guangheng Li; Karin Corsi-Payne; Bo Zheng; Arvydas Usas; Hairong Peng; Johnny Huard
Journal:  Tissue Eng Part A       Date:  2009-08       Impact factor: 3.845

Review 8.  Vascular endothelial growth factor control mechanisms in skeletal growth and repair.

Authors:  Kai Hu; Bjorn R Olsen
Journal:  Dev Dyn       Date:  2016-12-29       Impact factor: 3.780

Review 9.  Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate.

Authors:  Cristina Sobacchi; Eleonora Palagano; Anna Villa; Ciro Menale
Journal:  Front Bioeng Biotechnol       Date:  2017-05-17

10.  The transcriptional cofactor Lbh regulates angiogenesis and endochondral bone formation during fetal bone development.

Authors:  K L Conen; S Nishimori; S Provot; H M Kronenberg
Journal:  Dev Biol       Date:  2009-07-14       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.